Podcasts Business Investing The Meb Faber Show Mary Wheeler, BioRock Ventures - 2019...There Were 20 $1B Biopharma IPOs...We Just Dont Call Them Unicorns Because Theyre Not That Rare | #217

Mary Wheeler, BioRock Ventures - 2019...There Were 20 $1B Biopharma IPOs...We Just Dont Call Them Unicorns Because Theyre Not That Rare | #217

Published: May 4, 2020, 5 p.m.

b'In episode 217 we welcome our guest, Mary Wheeler, Founding Managing Director of BioRock Ventures. In today\\u2019s episode, we get into biotech and venture capital.\\nWe cover Mary\\u2019s deep background that ultimately influenced her investment focus on biotech. We cover her fund, BioRock Ventures, investing in biopharma startups, her core investment criteria, and keeping an eye out for companies serving unmet need areas.\\nWe touch on some key differences between biotech focused VC investing vs. other areas of VC. Mary even shares some insight into a company in her portfolio that has focused resources on potential COVID19 applications.\\nAll this and more in episode 217 with BioRock Ventures\\u2019 Mary Wheeler.\\nLearn more about your ad choices. Visit megaphone.fm/adchoices'